bestshares.com Logo
Popular
  • NVDA
    NVDA Nvidia
  • GOOGL
    GOOGL Alphabet Inc.
  • AAPL
    AAPL Apple Inc.
  • MSFT
    MSFT Microsoft Corporation
  • AMZN
    AMZN Amazon.com, Inc.
  • SPY
    SPY SPDR S&P 500 ETF Trust
  • QQQ
    QQQ Invesco QQQ Trust
    • CytoMed Therapeutics Limited logo

    CytoMed Therapeutics Limited

    GDTC | NASDAQ
    Chart Builder DCF Calculator
    $0.91
    -$0.07 (-7.14%)
    At close: Sep 21, 2026, 3:59 PM ET
    $0.86
    -$0.05 (-5.49%)
    After-hours: Sep 21, 2026, 4:34 PM ET
    Overview Rating Statistics Financials Earnings Analysts Ownership Profile

    Market Data

    Market Cap
    $11.48M
    Enterprise Value
    $12.3M
    Beta
    0.05
    Average Volume
    63K
    Shares Outstanding (Diluted)
    11.79M
    Shares Change YoY
    2.16%
    Institutional Ownership
    N/A
    Exchange
    NASDAQ
    ISIN
    SGXZ17669631

    Price Performance

    Price Change 1M
    -8.1%
    Price Change 3M
    -9.9%
    Price Change 6M
    -14.2%
    Price Change YTD
    -34.5%
    Price Change 1Y
    -52.9%
    Price Change 3Y
    -73.3%
    Price Change 5Y
    -77.3%
    1M CAGR (ann.)
    18.1%
    1Y CAGR (ann.)
    -48.4%
    5Y CAGR (ann.)
    N/A
    All-Time CAGR
    -33.8%

    Valuation

    PE Ratio
    -2.97
    Forward PE
    N/A
    PEG Ratio
    0.19
    Forward PEG
    0.19
    PS Ratio
    21.98
    Forward PS
    N/A
    PB Ratio
    2.13
    P/FCF Ratio
    -2.23
    P/Adj. FCF Ratio
    -2.19
    P/OCF Ratio
    -2.58
    EV/Sales
    19.15
    EV/EBIT
    -2.16
    EV/EBITDA
    -2.33
    EV/FCF
    -1.94
    Earnings Yield
    -34.4%
    FCF Yield
    -45.8%
    Adj. FCF Yield
    -46.7%

    Financial Health

    Net Cash
    S$1.69M
    Total Debt
    S$482.56K
    Cash & Short-Term Investments
    S$2.1M
    Total Assets
    S$7.98M
    Current Ratio
    5.17
    Quick Ratio
    3.66
    Debt / Equity Ratio
    0.07
    Debt / EBITDA
    -0.09
    Debt / FCF
    -0.08
    OCF / Debt
    -11.16
    Interest Coverage
    -209.99
    Altman Z-Score
    2.70
    Piotroski F-Score
    1

    Margins & Profitability

    Gross Profit Margin
    -20.5%
    Operating Profit Margin
    -672.2%
    EBITDA Margin
    -820.3%
    Net Profit Margin
    -754.7%
    FCF Margin
    -986.0%
    Adj. FCF Margin
    -1005.1%
    SBC / Revenue
    19.1%
    SBC Impact (per share)
    -1.9%

    Returns

    Return on Assets
    -60.7%
    Return on Equity
    -70.7%
    Return on Invested Capital
    -58.9%
    Return on Capital Employed
    -59.4%
    Return on Tangible Assets
    -61.7%

    Historical Growth (CAGR)

    Revenue CAGR 3Y
    20.8%
    Revenue CAGR 5Y
    61.0%
    Revenue CAGR 10Y
    N/A
    EPS CAGR 3Y
    8.7%
    EPS CAGR 5Y
    2.6%
    EPS CAGR 10Y
    N/A
    FCF CAGR 3Y
    -29.3%
    FCF CAGR 5Y
    -26.4%
    FCF CAGR 10Y
    N/A

    Analyst Forecasts

    Analyst Rating
    Hold
    Analyst Count
    0
    EPS Growth Next 3Y
    N/A
    Revenue Growth Next 3Y
    N/A
    Earnings Date
    Nov 12, 2026
    EPS Estimate (next Q)
    N/A
    EPS Growth Est (next Q)
    N/A
    Revenue Est (next Q)
    $113.2K
    Revenue Growth Est (next Q)
    -29.5%

    Cash Flow

    Operating Cash Flow
    S$-5.38M
    Free Cash Flow
    S$-6.34M
    Adj. Free Cash Flow
    S$-6.46M
    FCF Per Share
    -$0.54
    OCF Per Share
    -$0.46
    OCF/S Ratio
    -837.8%

    Income Statement

    Revenue
    S$642.64K
    Gross Profit
    S$-131.63K
    Operating Income
    S$-4.32M
    EBITDA
    S$-5.27M
    Net Income
    S$-4.85M
    EPS (Diluted)
    -$0.40
    Revenue / Employee
    $15.3K
    Profit / Employee
    $-115.47K
    Employees
    42

    © 2026 bestshares.com. All rights reserved.